What is Tympanogen?
Tympanogen is pioneering advancements in ENT medical devices, leveraging a proprietary gel technology to create novel solutions. The company's flagship product, Perf-Fix, is designed to revolutionize traditional tympanoplasty procedures. By enabling a quick, in-office application within approximately 10 minutes, Perf-Fix aims to eliminate the need for general anesthesia and extensive post-operative care, offering a less invasive and more efficient patient experience. This innovation holds the potential to significantly improve outcomes and accessibility for patients undergoing eardrum repair.
How much funding has Tympanogen raised?
Tympanogen has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2022): $1M with participation from NO/LA Angel Network
Key Investors in Tympanogen
NO/LA Angel Network
NO/LA Angel Network, also known as Gulf South Angels, is an investment network focused on providing financial backing and strategic guidance to emerging companies. They leverage their members' extensive experience to foster growth and deliver business insights, aiming to establish equitable deals and strong relationships with entrepreneurs.
What's next for Tympanogen?
With the recent major strategic investment and substantial total capital raised, Tympanogen is poised for significant growth and market penetration. The enterprise-level funding suggests a transition from the development phase towards commercialization and scaling of its unique gel-based medical technologies. Future strategic initiatives will likely focus on expanding manufacturing capabilities, securing regulatory approvals, and building out a robust sales and distribution network to support the adoption of Perf-Fix and other pipeline products within the ENT healthcare sector. This capital infusion is expected to accelerate Tympanogen's mission to enhance patient care through innovative medical device solutions.
See full Tympanogen company page
